XP patients with mutations in ERCC2 are characterized by photosensitivity; abnormality in skin pigmentations in the UV-exposed area of the body; neurodegeneration; and an increased risk of developing skin cancers, brain tumors, and tumors in other organs (B et al., 2018; Black, 2016). The gene discussed is ERCC2; the disease is skin neoplasm.